Atlas Trials

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

Clinical trial NCT01296035 · TERMINATED

Trial details

NCT number
NCT01296035
Sponsor
Women and Infants Hospital of Rhode Island
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Start date
2011-02-01
Primary completion
2013-10-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.